Division of Angiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
J Endocrinol Invest. 2021 Feb;44(2):339-345. doi: 10.1007/s40618-020-01309-2. Epub 2020 Jun 1.
Despite adequate glucocorticoid (GC) and mineralocorticoid (MC) replacement therapy, patients suffering from primary adrenal insufficiency (AI) have an increased mortality, mainly due to cardiovascular diseases. Only little knowledge exists on the contribution of MC substitution to the cardiovascular risk. Therefore, this study investigates the impact of plasma renin concentration on parameters of micro- and macrovascular function.
26 patients with primary AI [female = 18, age: 51 (28; 78) years; BMI: 24 (18; 40) kg/m; disease duration: 18 (5; 36) years] were included in this cross-sectional analysis. Intima media thickness (IMT) and pulse wave velocity (PWV) were investigated to assess macrovascular remodeling and arterial stiffness. Microvascular function was estimated by post-occlusive reactive hyperemia using laser Doppler fluxmetry. Baseline perfusion, biological zero, peak perfusion, time to peak and recovery time were recorded. Patients were grouped according to their median plasma renin concentration of previous visits (Renin vs Renin) and were compared to a group of healthy women [age: 44 (43; 46) years; BMI: 24.2 (21.8; 27.5)].
PWV was significantly higher in AI patients compared to controls [9.9 (5; 18.5) vs 7.3 (6.8; 7.7) m/s; p < .01], whereas no differences in microvascular function could be found. In Renin time to peak perfusion was significantly longer [6.0 (3; 15) vs 3.5 (1.5; 11) s; p < .05], whereas no differences in IMT and PWV were observed between Renin and Renin. No impact of GC dose was observed.
Microvascular function is not impaired in patients with primary AI under adequate replacement therapy, although higher renin concentrations are associated with subclinical improvements. No relation between RAAS activity and macrovascular function is observed, while arterial stiffness might be increased in primary AI.
尽管接受了充分的糖皮质激素(GC)和盐皮质激素(MC)替代治疗,原发性肾上腺功能不全(AI)患者的死亡率仍然较高,主要与心血管疾病有关。目前对于 MC 替代治疗对心血管风险的影响知之甚少。因此,本研究旨在调查血浆肾素浓度对微血管和大血管功能参数的影响。
本研究共纳入 26 例原发性 AI 患者(女性 18 例,年龄 51(28;78)岁,BMI 24(18;40)kg/m,疾病病程 18(5;36)年),进行了横断面分析。采用内中膜厚度(IMT)和脉搏波速度(PWV)评估大血管重构和动脉僵硬度。通过激光多普勒血流仪评估血管舒张功能,记录基础灌注、生物学零点、峰值灌注、达峰时间和恢复时间。根据以往就诊时的血浆肾素浓度中位数将患者分为两组(Renin 组和 Renin 组),并与一组健康女性(年龄 44(43;46)岁,BMI 24.2(21.8;27.5)kg/m)进行比较。
与对照组相比,AI 患者的 PWV 明显更高[9.9(5;18.5)比 7.3(6.8;7.7)m/s;p<0.01],而微血管功能无差异。Renin 组的时间至峰值灌注明显延长[6.0(3;15)比 3.5(1.5;11)s;p<0.05],而 IMT 和 PWV 两组间无差异。GC 剂量无影响。
在接受充分替代治疗的原发性 AI 患者中,微血管功能未受损,尽管较高的肾素浓度与亚临床改善相关。未观察到 RAAS 活性与大血管功能之间存在相关性,而原发性 AI 患者的动脉僵硬度可能增加。